Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CRYL1 |
| Upstream (Parents) |
|---|
| (<<) CES2 → CRYL1 |
| (<<) MUT → CRYL1 |
| (<<) DHRS1 → CRYL1 |
| (<<) HAGH → CRYL1 |
| Downstream (Children) |
|---|
| CRYL1 → C4orf31 (>>) |
| CRYL1 → TANC2 (>>) |
| CRYL1 → CYP17A1 (>>) |
| CRYL1 → VASH2 (>>) |
| CRYL1 → MEP1B (>>) |
| CRYL1 → RRN3P1 (>>) |
| CRYL1 → GPR172B (>>) |
| CRYL1 → TAS2R13 (>>) |
| CRYL1 → ADAMTS6 (>>) |
| CRYL1 → CPT1A (>>) |
| CRYL1 → CLDN15 (>>) |
| CRYL1 → LRRC2 (>>) |
